vs
EPR PROPERTIES（EPR）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是EPR PROPERTIES的1.1倍（$197.9M vs $182.9M），EPR PROPERTIES净利率更高（36.6% vs 6.7%，领先29.9%），REPLIGEN CORP同比增速更快（13.6% vs 3.2%），EPR PROPERTIES自由现金流更多（$269.2M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 4.6%）
EPR地产（前身为娱乐地产信托）是总部位于美国密苏里州堪萨斯城的房地产投资信托企业，专注投资游乐园、电影院、滑雪度假村等娱乐类地产项目，截至2022年共持有353处物业。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
EPR vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$182.9M
营收增速更快
RGEN
高出10.4%
3.2%
净利率更高
EPR
高出29.9%
6.7%
自由现金流更多
EPR
多$251.7M
$17.6M
两年增速更快
RGEN
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $182.9M | $197.9M |
| 净利润 | $66.9M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 56.8% | 9.0% |
| 净利率 | 36.6% | 6.7% |
| 营收同比 | 3.2% | 13.6% |
| 净利润同比 | 897.0% | 143.9% |
| 每股收益（稀释后） | $0.80 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EPRRGEN
| Q4 25 | $182.9M | $197.9M | ||
| Q3 25 | $182.3M | $188.8M | ||
| Q2 25 | $178.1M | $182.4M | ||
| Q1 25 | $175.0M | $169.2M | ||
| Q4 24 | $177.2M | $174.1M | ||
| Q3 24 | $180.5M | $154.9M | ||
| Q2 24 | $173.1M | $154.1M | ||
| Q1 24 | $167.2M | $151.3M |
净利润EPRRGEN
| Q4 25 | $66.9M | $13.3M | ||
| Q3 25 | $66.6M | $14.9M | ||
| Q2 25 | $75.6M | $14.9M | ||
| Q1 25 | $65.8M | $5.8M | ||
| Q4 24 | $-8.4M | $-30.3M | ||
| Q3 24 | $46.6M | $-654.0K | ||
| Q2 24 | $45.1M | $3.3M | ||
| Q1 24 | $62.7M | $2.1M |
毛利率EPRRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率EPRRGEN
| Q4 25 | 56.8% | 9.0% | ||
| Q3 25 | 53.5% | 8.9% | ||
| Q2 25 | 62.5% | 7.6% | ||
| Q1 25 | 58.1% | 3.9% | ||
| Q4 24 | 25.5% | -17.7% | ||
| Q3 24 | 51.4% | -5.1% | ||
| Q2 24 | 45.9% | 1.0% | ||
| Q1 24 | 58.8% | 1.3% |
净利率EPRRGEN
| Q4 25 | 36.6% | 6.7% | ||
| Q3 25 | 36.5% | 7.9% | ||
| Q2 25 | 42.5% | 8.2% | ||
| Q1 25 | 37.6% | 3.4% | ||
| Q4 24 | -4.7% | -17.4% | ||
| Q3 24 | 25.8% | -0.4% | ||
| Q2 24 | 26.1% | 2.2% | ||
| Q1 24 | 37.5% | 1.4% |
每股收益（稀释后）EPRRGEN
| Q4 25 | $0.80 | $0.24 | ||
| Q3 25 | $0.79 | $0.26 | ||
| Q2 25 | $0.91 | $0.26 | ||
| Q1 25 | $0.78 | $0.10 | ||
| Q4 24 | $-0.19 | $-0.55 | ||
| Q3 24 | $0.53 | $-0.01 | ||
| Q2 24 | $0.51 | $0.06 | ||
| Q1 24 | $0.75 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.6M | $767.6M |
| 总债务越低越好 | $2.9B | $542.2M |
| 股东权益账面价值 | $2.3B | $2.1B |
| 总资产 | $5.7B | $2.9B |
| 负债/权益比越低杠杆越低 | 1.26× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资EPRRGEN
| Q4 25 | $90.6M | $767.6M | ||
| Q3 25 | $13.7M | $748.7M | ||
| Q2 25 | $13.0M | $708.9M | ||
| Q1 25 | $20.6M | $697.2M | ||
| Q4 24 | $22.1M | $757.4M | ||
| Q3 24 | $35.3M | $784.0M | ||
| Q2 24 | $33.7M | $809.1M | ||
| Q1 24 | $59.5M | $780.6M |
总债务EPRRGEN
| Q4 25 | $2.9B | $542.2M | ||
| Q3 25 | $2.8B | $537.9M | ||
| Q2 25 | $2.8B | — | ||
| Q1 25 | $2.8B | — | ||
| Q4 24 | $2.9B | $525.6M | ||
| Q3 24 | $2.9B | — | ||
| Q2 24 | $2.8B | — | ||
| Q1 24 | $2.8B | — |
股东权益EPRRGEN
| Q4 25 | $2.3B | $2.1B | ||
| Q3 25 | $2.3B | $2.1B | ||
| Q2 25 | $2.3B | $2.1B | ||
| Q1 25 | $2.3B | $2.0B | ||
| Q4 24 | $2.3B | $2.0B | ||
| Q3 24 | $2.4B | $2.0B | ||
| Q2 24 | $2.4B | $2.0B | ||
| Q1 24 | $2.4B | $2.0B |
总资产EPRRGEN
| Q4 25 | $5.7B | $2.9B | ||
| Q3 25 | $5.5B | $2.9B | ||
| Q2 25 | $5.6B | $2.9B | ||
| Q1 25 | $5.5B | $2.9B | ||
| Q4 24 | $5.6B | $2.8B | ||
| Q3 24 | $5.7B | $2.8B | ||
| Q2 24 | $5.6B | $2.9B | ||
| Q1 24 | $5.7B | $2.8B |
负债/权益比EPRRGEN
| Q4 25 | 1.26× | 0.26× | ||
| Q3 25 | 1.19× | 0.26× | ||
| Q2 25 | 1.20× | — | ||
| Q1 25 | 1.20× | — | ||
| Q4 24 | 1.23× | 0.27× | ||
| Q3 24 | 1.19× | — | ||
| Q2 24 | 1.16× | — | ||
| Q1 24 | 1.15× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $421.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $269.2M | $17.6M |
| 自由现金流率自由现金流/营收 | 147.1% | 8.9% |
| 资本支出强度资本支出/营收 | 82.9% | 4.1% |
| 现金转化率经营现金流/净利润 | 6.29× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $568.5M | $93.9M |
8季度趋势，按日历期对齐
经营现金流EPRRGEN
| Q4 25 | $421.0M | $25.7M | ||
| Q3 25 | $136.5M | $48.1M | ||
| Q2 25 | $87.3M | $28.6M | ||
| Q1 25 | $99.4M | $15.0M | ||
| Q4 24 | $393.1M | $39.2M | ||
| Q3 24 | $122.0M | $49.3M | ||
| Q2 24 | $78.7M | $42.2M | ||
| Q1 24 | $99.5M | $44.7M |
自由现金流EPRRGEN
| Q4 25 | $269.2M | $17.6M | ||
| Q3 25 | $132.1M | $43.4M | ||
| Q2 25 | $82.4M | $21.5M | ||
| Q1 25 | $84.7M | $11.4M | ||
| Q4 24 | $129.2M | $33.6M | ||
| Q3 24 | $121.5M | $42.3M | ||
| Q2 24 | $71.3M | $37.4M | ||
| Q1 24 | $65.0M | $36.4M |
自由现金流率EPRRGEN
| Q4 25 | 147.1% | 8.9% | ||
| Q3 25 | 72.5% | 23.0% | ||
| Q2 25 | 46.3% | 11.8% | ||
| Q1 25 | 48.4% | 6.8% | ||
| Q4 24 | 72.9% | 19.3% | ||
| Q3 24 | 67.3% | 27.3% | ||
| Q2 24 | 41.2% | 24.3% | ||
| Q1 24 | 38.9% | 24.0% |
资本支出强度EPRRGEN
| Q4 25 | 82.9% | 4.1% | ||
| Q3 25 | 2.4% | 2.5% | ||
| Q2 25 | 2.7% | 3.9% | ||
| Q1 25 | 8.4% | 2.1% | ||
| Q4 24 | 148.9% | 3.2% | ||
| Q3 24 | 0.3% | 4.5% | ||
| Q2 24 | 4.2% | 3.1% | ||
| Q1 24 | 20.6% | 5.5% |
现金转化率EPRRGEN
| Q4 25 | 6.29× | 1.93× | ||
| Q3 25 | 2.05× | 3.23× | ||
| Q2 25 | 1.15× | 1.92× | ||
| Q1 25 | 1.51× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.62× | — | ||
| Q2 24 | 1.74× | 12.70× | ||
| Q1 24 | 1.59× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EPR
| Experiential Reportable Operating Segment | $173.3M | 95% |
| Education Reportable Operating Segment | $9.5M | 5% |
RGEN
暂无分部数据
